Skip to main content
. 2014 Nov 5;349:g6427. doi: 10.1136/bmj.g6427

Table 3.

 Recommended duration (months) of dual antiplatelet therapy and follow-up treatment in three of five trials in meta-analysis of effects of bare metal stent (BMS) or cobalt-chromium everolimus eluting (DES) on fatal and non-fatal cardiovascular events

PRODIGY (n=1003) EXAMINATION (n=1498) BASKET PROVE (n=1539) SPIRIT I (n=56) XIMA (n=800)
Experimental arm 6 or 24* 12 12 ≥3 12
Control arm Up to 6 or 24* 12 12 ≥3 3
Follow-up (years) 2 2 2 5 1

*1:1 randomisation.